Cannabis

Switzerland further benefits from a population with a high disposable income despite the Swiss economy being set to grow at a significantly below-average rate throughout 2023. Inflation is expected to be 2.3 % in 2023. The dampening effects of…

The cannabis market has experienced significant turmoil due to uncertainties arising from the actions of the Thai Government. Subsequently, there was a noticeable decline in consumer confidence in legal cannabis consumption in 2023. While demand…

This report analyses the market for cannabis in Spain. For the purposes of the study, the market has been defined as follows:

The penetration of medical cannabis continues to increase in the Italian market, with the number of legal patients growing due to the increased availability of supplies in the country. Indeed, thanks to the introduction of new products and several…

The legal cannabis market in South Africa has continued to see strong growth on the back of the landmark judgement in 2018, which determined private use and consumption of cannabis as legal within private spaces. As an example, private spaces include…

This report analyses the market for cannabis in the Netherlands. For the purposes of the study, the market has been defined as follows:

Argentina faced an uncertain macroeconomic scenario due to political disfunction and economic instability, with one of the highest inflation rates in the world, although according to Comisión Económica para América Latina y Caribe (CEPAL), gross…

Colombia, historically linked with drug trafficking, has undergone a noteworthy transformation by actively cultivating a well-regulated cannabis industry. The legalisation of medical cannabis, the establishment of a legal framework for licensed…

Cannabis sales growth is being driven by adult-use cannabis, with a growing user base linked to the illicit market, growing social acceptance and fair pricing. Heightened consumer stress as a result for inflation is also encouraging growing use,…

Since mid-2022, inflationary pressures and the decline in disposable incomes have had an impact on Cannabis product consumption in Greece. On the one hand, the cost of living crisis is taking its toll on consumer spending on Cannabis products. These…

Currently, there are no sales of medical cannabis in Japan, although the illegal cannabis market continues to grow, along with legal CBD & other non-intoxicating cannabinoids. However, an amendment to Japan’s Cannabis Control Law was passed in…

The cannabis market in Mexico is estimated to be worth MXN33,650 million, with 95% of it being sold through the illicit market.

Medical cannabis remains stagnant in Portugal. New medications have not been introduced in the market in the last couple of years, the prices of those available continue to be high by Portuguese standards, cannabis producers’ focus continues to be on…

The cannabis culture in Chile is at an intermediate stage of development compared to other countries in Latin America. Since decriminalisation of cannabis for medicinal use in 2016, Chile has witnessed an explosion in “grow shops” and home growing to…

Cannabis in the US has seen a significant slowdown in growth in recent years, albeit with a still positive performance, and showing many indications of more robust growth over the forecast period. Although near-term federal legalisation is less…

In 2023, growth in the number of medical cannabis patients slowed significantly in Israel. In the first half of the year the number of medical patients grew by only 1,500; meanwhile, in 2021 monthly growth averaged 2,400, while in 2022 it was 1,220.…

Poland has become a strategic powerhouse for FMCG industries in Eastern Europe in the past two decades, and especially during the current geopolitical climate. The cannabis market is still in its infancy in Poland; however, a range of factors sets a…

The so-called “traffic-light” coalition is attempting to revolutionise Germany’s drug policy. The current plan to legalise cannabis is, however, a rather cautious approach to that. Yet, the debate has shown how much cannabis is already part of many…

Contrary to expectations, the national government did not advance hemp legislation for medical and industrial purposes in 2023. Instead, it opted to sidestep a potentially contentious debate, prioritising a comprehensive tax reformulation on its…

The approval of medical cannabis has been postponed again to 2024 according to official sources. However, it is estimated that its full implementation will be further delayed. France began its medical trial in 2021. It was set to be a 2-year pilot…